Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Fibroblast growth factor receptor 1 [308-731] | ||
Ligand | BDBM350083 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | LanthaScreen Assay | ||
IC50 | 2.40±n/a nM | ||
Citation | Andrews, SW; Blake, JF; Cook, A; Gunawardana, IW; Hunt, KW; Metcalf, AT; Moreno, D; Ren, L; Tang, TP 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases US Patent US10766881 Publication Date 9/8/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Fibroblast growth factor receptor 1 [308-731] | |||
Name: | Fibroblast growth factor receptor 1 [308-731] | ||
Synonyms: | BFGFR | CEK | FGFBR | FGFR1 | FGFR1_HUMAN | FLG | FLT2 | Fibroblast growth factor receptor 1 (FGFR1)(aa 308-731) | HBGFR | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 47326.25 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 308-731 | ||
Residue: | 424 | ||
Sequence: |
| ||
BDBM350083 | |||
n/a | |||
Name | BDBM350083 | ||
Synonyms: | US10208024, Example 82 | US10766881, Example 82 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H30F2N8O4 | ||
Mol. Mass. | 568.5751 | ||
SMILES | COCCN1CCC(CC1)n1cc(cn1)-c1cnc(N)c(n1)-c1ccc(=O)n(n1)-c1c(F)c(OC)cc(OC)c1F |(-13.14,-4.41,;-12.37,-3.08,;-10.83,-3.08,;-10.06,-1.75,;-8.52,-1.75,;-7.75,-.41,;-6.21,-.41,;-5.44,-1.75,;-6.21,-3.08,;-7.75,-3.08,;-3.9,-1.75,;-3,-.5,;-1.53,-.98,;-1.53,-2.52,;-3,-2.99,;-.2,-.21,;-.2,1.33,;1.14,2.1,;2.47,1.33,;3.8,2.1,;2.47,-.21,;1.14,-.98,;3.8,-.98,;3.8,-2.52,;5.14,-3.29,;6.47,-2.52,;7.81,-3.29,;6.47,-.98,;5.14,-.21,;7.81,-.21,;9.14,-.98,;9.14,-2.52,;10.47,-.21,;11.81,-.98,;13.14,-.21,;10.47,1.33,;9.14,2.1,;9.14,3.64,;10.47,4.41,;7.81,1.33,;6.47,2.1,)| | ||
Structure |